-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Initiates Coverage On Tvardi Therapeutics with Buy Rating, Announces Price Target of $39

Benzinga·04/28/2025 12:14:31
Listen to the news
Jones Trading analyst Debanjana Chatterjee initiates coverage on Tvardi Therapeutics (NASDAQ:TVRD) with a Buy rating and announces Price Target of $39.